United Therapeutics Balance Sheet - Quarterly (NASDAQ:UTHR)

Add to My Stocks
$126.2 $0.26 (0.21%) UTHR stock closing price Sep 18, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at United Therapeutics balance sheet. As in our United Therapeutics stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results are typically accompanied with the company releasing financial statements. Apart from analyzing United Therapeutics revenue United Therapeutics operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The United Therapeutics balance sheet for 2018 Q2 shows cash on hand of $745.9M. The company has a debt to equity ratio of 0.1.

View and download United Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash745.9M932.7M705.1M1.07B1.01B1.12B1.02B953M837.5M846.8M
Marketable Securities467.1M324.1M222.3M143.2M109.3M33.7M27.8M79.6M107.2M128.3M
Receivables251.3M211.1M297.1M251.8M273.9M188M214.5M224.6M238.1M194.8M
Inventory102.7M101.5M107.9M114.4M114.1M106.9M100M92.4M89.1M87.6M
Raw Materials27.1M24.9M27.9M27.5M29.1M26.5M25.4M24.7M24.8M23.2M
Work In Progress25.9M24.5M24.1M24.7M23.4M22.9M24.9M26.2M27M26.3M
Finished Goods49.7M52.1M55.9M62.2M61.6M57.5M49.7M41.5M37.3M38.1M
Notes Receivable----------
Other Current Assets57.2M64.2M115.5M62.3M60.5M52.9M59.5M36.4M43.5M42.1M
Total Current Assets
1.62B1.63B1.45B1.64B1.56B1.5B1.42B1.39B1.32B1.3B
Property Plant & Equipment--748.2M---664.3M---
Accumulated Depreciation--202.5M---175M---
Net Property Plant & Equipment
626.1M577.5M545.7M521.7M501.9M493.5M489.3M488.4M490.6M495.2M
Investment & Advances578.3M414.8M502.7M338.5M216.2M144.5M2.3M2.3M3.9M10.7M
Other Non-Current Assets----------
Deferred Charges113.4M113.4M113.4M177.9M178M181.5M178.3M188.8M188.1M192.5M
Intangibles45.6M45.6M45.6M45.7M45.8M33.6M33.8M34M34.1M34.3M
Deposits & Other Assets257.3M235.3M224.1M213M185.9M204.1M197.1M169.7M169.4M159.8M
Total Assets
3.24B3.02B2.88B2.94B2.69B2.56B2.33B2.27B2.2B2.19B
Notes Payable---------220.27M
Accounts Payable216M203.4M171.1M143.3M126.8M105.6M104.2M119M124M106.6M
Current Portion Long-Term Debt---250M250M----5.4M
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities134M115M273.6M396.1M462M322.1M228.3M195.6M167.5M245.1M
Total Current Liabilities
350M318.4M444.7M789.4M838.8M427.7M332.5M314.6M292.4M357.1M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt250M250M250M-------
Non-Current Capital Leases----------
Other Long-Term Liabilities79.3M82.4M82.9M76.7M76.6M68.3M141.8M115.9M102.9M123.2M
Total Liabilities
679.3M650.8M777.6M866.1M915.4M496M474.3M430.5M395.3M480.3M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus1.9B1.88B1.85B1.84B1.79B1.8B1.81B1.84B1.83B1.8B
Retained Earnings3.26B3.09B2.85B2.83B2.55B2.61B2.43B2.32B2.16B1.96B
Treasury Stock2.58B2.58B2.58B2.58B2.54B2.33B2.38B2.31B2.17B2.03B
Other Liabilities-21.9M-21.7M-19.6M-16.8M-16.6M-16.7M-16.8M-16.8M-14.7M-19.8M
Shareholders Equity2.57B2.37B2.1B2.07B1.78B2.07B1.85B1.84B1.81B1.71B
Total Liabilities & Shareholders Equity3.24B3.02B2.88B2.94B2.69B2.56B2.33B2.27B2.2B2.19B
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at United Therapeutics historical stock prices and the current United Therapeutics stock price can tell you how the stock price has moved, whereas the United Therapeutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: UTHR total assets, which was at $3.24B for 2018 Q2 is a balance sheet item representing value of what United Therapeutics owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case United Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for UTHR stock stand at $679.3M.

United Therapeutics Balance Sheet - Key Ratios

Current ratio
4.64
Debt to equity ratio
0.1
Asset turnover ratio
0.57
Receivables turnover
6.79
Price to book ratio
2.5

Quarterly Balance Sheets For United Therapeutics Corporation Peers

Baxter International balance sheet, CORREVIO PHARMA balance sheet, Pfizer balance sheet